Zinc alters conformation and inhibits biological activities of nerve growth factor and related neurotrophins

Nature Medicine

Volumn 3, Issue 8, 1997, Pages 872-878

  Ross, Gregory M ^a   Shamovsky, Igor L ^a   Lawrance, Gail ^a   Solc, Mark ^a   Dostaler, Suzanne M ^a   Jimmo, Sandra L ^a   Weaver, Donald F ^a   Riopelle, Richard J ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN;

ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; HORMONE ACTION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

ANIMALS; CHICKENS; MICE; NERVE GROWTH FACTORS; NEURITES; PC12 CELLS; PROTEIN BINDING; PROTEIN CONFORMATION; RATS; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; ZINC;

ANIMALIA;

EID: 0030813960     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0897-872     Document Type: Article

References (54)

1. Smart, T.G., Xie, X. & Krishek, B.J. Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc. Prog. Neurobiol. 42, 393-441 (1994).
2. Xie, X. & Smart, T.G. A physiological role for endogenous zinc in rat hippocampal synaptic neurotransmission. Nature 349, 521-524 (1991).
3. Bush, A.I. et al. Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265, 1464-1467 (1993).
4. 2+: An endogenous modulator of ligand- and voltage-gated ion channels. Neuropharmcology 33, 935-952 (1994).
5. Koh, J.-Y. et al. The role of zinc in selective neuronal death after global cerebral ischemia. Science 272, 1013-1016 (1996).
6. Lindvall, O., Kokaia, Z., Bengzon, J., Elmér, E. & Kokaia, M. Neurotrophins and brain insults. Trends Neurosci. 17, 490-499 (1994).
7. Levi-Montalcini, R. The nerve growth factor 35 years later. Science 237, 1154-1162 (1987).
8. Frade, J.M., Rodríguez-Tébar, A. & Barde, Y.-A. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383, 166-168 (1996).
9. Casaccia-Bonnefil, P., Carter, B.D., Dobrowsky, R.T. & Chao, M.V. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383, 716-719 (1996).
10. NGFR-deficient mice. Science 274, 1729-1732 (1996).
11. Chao, M.V. & Hempstead, B.L. p75 and Trk: A two-receptor system. Trends Neurosci. 18, 321-326 (1995).
12. McDonald, N.Q. et al. A new protein fold revealed by the 2.3Å resolution crystal structure of nerve growth factor. Nature 354, 411-414 (1991).
13. Holland, D.R., Cousens, L.S., Meng, W. & Mathews, B.W. Nerve growth factor in different crystal forms displays structural flexibility and reveals zinc binding sites. J. Mol. Biol. 238, 385-400 (1994).
14. Bradshaw, R.A. et al. Nerve growth factor: Structure/function relationships. Protein Science 3, 1901-1913 (1994).
15. Ibáñez, C.F. Neurotrophic factors: From structure-function studies to designing effective therapeutics. Trends Biotech. 13, 217-227 (1995).
16. Shih, A., Laramee, G.R., Schmelzer, C.H., Burton, L.E. & Winslow, J.W. Mutagenesis identifies amino-terminal residues of nerve growth factor necessary for trk receptor binding and biological activity. J. Biol. Chem. 269, 27679-27686 (1994).
17. Shamovsky, I.L., Ross, G.M., Riopelle, R.J. & Weaver, D.F. Theoretical studies on the bioactive conformation of nerve growth factor using VBMC - A novel variable basis Monte Carlo simulated annealing algorithm for peptides. J. Am. Chem. Soc. 118, 9743-9749 (1996).
18. Ibáñez, C.F. et al. Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell 69, 329-341 (1992).
19. Woo, S.B. & Neet, K.E. Characterization of histidine residues essential for receptor binding and activity of nerve growth factor. J. Biol. Chem. 271, 24433-24441 (1996).
20. Greene, L.A. & Tischler, A.S. Establishment of a noradrenergic clonal cell line of rat pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73, 2424-2432 (1976).
21. Kaplan, D.R., Matin-Zanca, D. & Parada, L.F. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 350, 158-160 (1991).
22. Kaplan, D.R., Hempstead, B.L., Martin-Zanca, D.,Chao, M.V. & Parada, L.F. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 252, 554-558 (1991).
23. Zhang, D. et al. Atrolysin C. Protein Data Bank (Brookhaven National Laboratory, Upton, NY), accession code 1ATL.
24. Sarkar, B. Peptide models for the metal-binding sites of proteins and enzymes. J. Indian Chem. Soc. 59, 1403-1411 (1982).
25. Vedani, A., Huhta, D.W. & Jacober, S.P. Metal coordination, H-bond network formation, and protein-solvent interactions in native and completed human carbonic anhydrase l: A molecular mechanics study. J. Am. Chem. Soc. 111, 4075-1081 (1989).
26. Argos, P., Garavito, R.M., Eventoff, W. & Rossmann, M.G. Similarities in active center geometries of zinc-containing enzymes, proteases and dehydrogenases. J. Mol. Biol. 126, 141-158 (1978).
27. 4H motifs encode a local structural switch. Biochemistry 30, 9396-9402 (1991).
28. 4-Cys peptide binds metal ions: Spectroscopic studies and a proposed three-dimensional structure. Proc. Natl. Acad. Sci. USA 86, 4047-4051 (1989).
29. Bertini, I., Luchinat, C. & Scozzafava, A. Carbonic anhydrase: An insight into the zinc binding site and into the active cavity through metal substitution, in: Structure and Bonding, Vol. 48, 45-92 (Springer-Verlag, Berlin-Heidelberg, 1982).
30. Tainer, J.A., Getzoff, E.D., Beem, K.M., Richardson, J.S. & Richardson, D.C. Determination and analysis of the 2Å structure of copper, zinc superoxide dismutase. J. Mol. Biol. 160, 181-217 (1982).
31. 2O of zinc enzymes. Proc. Natl. Acad. Sci USA 87, 220-224 (1990).
32. Sheridan, R.P. & Allen, L.C. The active site electrostatic potential of human carbonic anhydrase. J. Am. Chem. Soc. 103, 1544-1550 (1981).
33. Cunningham, B.C., Mulkerrin, M.G. & Wells, J.A. Dimerization of human growth hormone by zinc. Science 253, 545-548 (1991).
34. Somers, W., Ulsch, M., De Vos, A.M. & Kossiakoff, A.A. The X-ray structure of a growth hormone-prolactin receptor complex. Nature 372, 478-481 (1994).
35. Matthews, D.J. & Wells, J.A. Engineering an interfacial zinc site to increase hormone-receptor affinity. Chem. Biol. 1, 25-30 (1994).
36. Dostaler, S.M. et al. Characterization of a distinctive motif of the low molecular weight neurotrophin receptor that modulates NGF-mediated neurite growth, Eur. J. Neurosci. 8, 870-879 (1996).
37. Rylett, R.J. & Williams, L.R. Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. Trends Neurosci. 17, 486-490 (1994).
38. Ben-Ari, Y. & Represa, A. Brief seizure episodes induce long-term potentiation and mossy fibre sprouting in the hippocampus. Trends Neurosci. 13, 312-318 (1990).
39. Rashid, K. et al. A nerve growth factor peptide retards seizure development and inhibits neuronal sprouting in a rat model of epilepsy. Proc. Natl. Acad. Sci. USA 92, 9495-9499 (1995).
40. Lewin, G.R. & Mendell, L.M. Nerve growth factor and nociception. Trends Neurosci. 16, 353-359 (1993).
41. Woolf, C.J. & Doubell, T.A. The pathophysiology of chronic pain -increased sensitivity to low threshold Aβ-fibre inputs. Curr. Opin. Neurobiol. 4, 525-534 (1994).
42. McMahon, S.B., Bennett, D.L.H., Priestley, J.V. & Shelton, D.L. The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-lgG fusion molecule. Nature Med. 1, 774-780 (1994).
43. Hancock, R.D. & Martell, A.E. Ligand design for selective complexation of metal ions in agueous solutions. Chem. Rev. 89, 1875-1914 (1989).
44. Gregory, D.S., Martin, A.C.R., Cheetham, J.C. & Rees, A.R. The prediction and characterization of metal binding sites in proteins. Protein Eng. 6, 29-35 (1993).
45. Brooks, B.R. et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4, 187-217 (1983).
46. Dent, A.J., Beyersmann, D., Block, C. & Hasnain, S.S. Environment of zinc sites in 5-aminoaevulinate dehydratase. Physica B 158, 95-96 (1989).
47. Robinson, R.C., Radziejewski, C., Stuart, D.I. & Jones, E.Y. Structure of the brain-derived neurotrophic factor/neurotrophin-3 heterodimer. Biochemistry 34, 4139-4146 (1995).
48. Sutter, A., Riopelle, R.J., Harris-Warrick, R.M. & Shooter, E.M. Nerve growth factor receptors. J. Biol. Chem. 254, 5972-5982 (1979).
49. Connolly, D.T., Knight, M.B., Harakas, N.K., Wittwer, A.J. & Feder, J. Determination of the number of endothelial cells in culture using an acid phosphatase assay. Anal. Biochem. 152, 136-140 (1986).
50. Ueda, Y., Walsh, E., Nakanishi H. & Yoshida, K. A colorimetric assay method for the evaluation of neurotrophic activity in vitro. Neurosci. Lett. 165, 203-207 (1994).
51. Mesner, P.W., Winters, T.R. & Green, S.H. Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons. J. Cell Biol. 119, 1669-1680 (1992).
52. Batistatou, A. & Greene, L.A. Aurintricarbonic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: Correlation with suppression of endonuclease activity. J. Cell Biol. 115, 461-471 (1991).
53. Rukenstein, A., Rydel, R.E. and Greene, L.A. Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms. J. Neurosci. 11, 2552-2563 (1991).
54. Greene, L.A. Nerve growth factor prevents the death and stimulates neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J. Cell Biol. 78, 747-755 (1978).